🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7731939

Vaccine compositions and adjuvant

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723500

Immunostimulatory nucleic acid molecules

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723111

Activated dual specificity lymphocytes and their methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723096

Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723022

Immunostimulatory nucleic acid molecules

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7722889

Plasmodium liver stage antigens

The United States of America as represented by the Secretary of the Army · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7718779

Prophylactic and therapeutic monoclonal antibodies

The United States of America as represented by the Secretary of the Army · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7718424

AAV4 vector and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7718196

Rapamycin-resistant T cells and therapeutic uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7718183

Proteins with repetitive bacterial-Ig-like (big) domains present in Leptospira species

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7713529

Methods for treating and preventing infectious disease

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7709609

Tumor suppressor gene, p47ING3

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7709252

Antibodies, including FV molecules, and immunoconjugates having high binding affinity for

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7709007

Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide seque

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7709002

Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7704509

Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of reco

The United States of America · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7704491

Recombinant human metapneumovirus and its use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7700600

Methods for treating cardiac arrhythmia

The United States of America · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7700273

Peptidomimetics that mimic a conformational-dependent neutralizing epitope of the human im

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7696338

Immunotoxin fusion proteins and means for expression thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7691579

Methods and compositions for producing an enhanced immune response to a human papillomavir

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7691386

Chimeric papillomavirus-like particles

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7687610

Human chorionic gonadotropin superagonists

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7683095

Compositions and methods of treating, reducing and preventing cardiovascular diseases and

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted